Back to Search
DAVID HELLERSTEIN, MD
MD
Psychiatry Physician
NPI: 1710031067Individual
Specialties, Licenses & Credentials
Clinical Trials (6)
6
Linked Trials
0
Recruiting
5
With Results
Desvenlafaxine vs. Placebo Treatment of Chronic Depression
NCT01537068COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Duloxetine for Chronic Depression: a Double-blind Study
NCT00360724COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Abilify as an Adjunctive Treatment for Refractory Depression
NCT00220636COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Wellbutrin XL for Dysthymic Disorder
NCT00225251COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Escitalopram in the Treatment of Dysthymic Disorder, Double Blind
NCT00220701COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo
NCT00334048COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
A randomized controlled trial of desvenlafaxine-induced structural brain changes in the treatment of persistent depressive disorder.
PMID 36996664·Psychiatry Res Neuroimaging·2023
2-rct
Serotonin-norepinephrine reuptake inhibitor antidepressant effects on regional connectivity of the thalamus in persistent depressive disorder: evidence from two randomized, double-blind, placebo-controlled clinical trials.
PMID 35592490·Brain Commun·2022
8-other
Effects of the antidepressant medication duloxetine on brain metabolites in persistent depressive disorder: A randomized, controlled trial.
PMID 31323045·PLoS One·2019
2-rct
Desvenlafaxine vs. placebo in the treatment of persistent depressive disorder.
PMID 30423468·J Affect Disord·2019
2-rct
Do social functioning and symptoms improve with continuation antidepressant treatment of persistent depressive disorder? An observational study.
PMID 28064115·J Affect Disord·2017
2-rct
A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
PMID 22901348·J Clin Psychiatry·2012
4-observational
Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials.
PMID 21527126·J Clin Psychiatry·2011
1-meta
Escitalopram versus placebo in the treatment of dysthymic disorder.
PMID 21811192·Int Clin Psychopharmacol·2010
2-rct
A double-blind, placebo-controlled study of the efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder.
PMID 17503976·J Clin Psychiatry·2007
4-observational
Sexual function and dysfunction during treatment with psychotropic medications.
PMID 16420088·J Clin Psychiatry·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 271 WEST 70TH ST. SUITE #1F, DAVID HELLERSTEIN
NEW YORK, NY 10023 - Phone
- (212) 875-1357
Quick Facts
- NPI
- 1710031067
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile